Head of Patient-Facing Quality Assurance

CSL; Maidenhead; Hybrid; GBP 120,000 - 180,000; Full time

Job summary

Seqirus seeks a seasoned leader to head Patient-Facing Quality Assurance, unifying clinical and pharmacovigilance quality. You will shape the quality strategy, oversee GCP/GVP activities and ensure participant safety, data integrity and regulatory readiness across global trials.

You will lead global QA programs, manage budget and vendor relationships, and drive Quality by Design while aligning with enterprise QMS. Hybrid role with international travel expectations.

Qualifications

• Degree in life sciences or related field.
• 10+ years in pharma/regulated life sciences.
• Proven leadership of global QA teams.
• Experience with GCP and GVP regulation and inspections.
• Oversight of CROs, vendors and partners.

Responsibilities

• Provide independent, risk-based QA oversight from trial design through close-out.
• Lead global QA strategy, operating model and governance for Clinical QA and PV QA.
• Drive Quality by Design and risk-based quality management across programs.
• Prepare and respond to health-authority inspections and audits.
• Oversee safety data handling, SUSARs, SAE reconciliation and reportability.

Skills

GCP leadership

GVP leadership

ICH E6(R3)

Regulatory inspections

Budget & teams

CRO/vendor management

Education

Life sciences degree

Advanced degree in Quality/GCP/GVP/audit

Job description

Head of Patient-Facing Quality Assurance# CSL採用情報へようこそ## Head of Patient-Facing Quality Assurance応募: Seqirus UK - Maidenhead: Seqirus USA - MA - Waltham: 正社員: 募集開始 - 今日: R-274196**The Role**Every clinical trial depends on a commitment to the people who take part: their rights, safety and wellbeing come first, and the data they help generate can be trusted. Once a product reaches patients, that commitment continues through the monitoring of its safety and benefit-risk. This role holds the organisation to both. As Head of Patient-Facing Quality Assurance, you will lead an integrated QA organisation covering Good Clinical Practice and Good Pharmacovigilance Practice, reporting to the Head of Global R&D Quality. Your team will include PV System and Process Leads, Therapeutic Area Quality Leads, and a Head of Clinical QA or of PV and Regulatory QA, depending on which complements your own background. *Hybrid (3 days a week on site), based in Maidenhead, UK, or King of Prussia, PA, with other global locations open to discussion* **Why it matters**Bringing clinical and pharmacovigilance quality under one leader is a deliberate choice. Some of the most consequential risks sit at the interfaces between them: serious adverse event reconciliation, expedited reporting, and the safety information that reaches investigators and regulators. A single function can see these clearly and act on them. The role is also a chance to shape how quality is done, not just police it. With ICH E6(R3) moving the industry toward Quality by Design and risk-based quality management, you will set the strategy, operating model and standards for how the company protects participants and patients. You will keep the specialist depth that GCP and GVP each need while making the approach consistent worldwide. **What You’ll Be Responsible For**You will provide independent, risk-based QA oversight from trial design through close-out, and across the global pharmacovigilance system. You will be the consistent quality voice in governance and a constructive challenger to the functions that own operational delivery.* Setting the strategy, operating model, governance, capabilities and global resource model for Clinical QA and PV QA, harmonising approaches without diluting specialist expertise* Embedding Quality by Design, critical-to-quality factors and risk-based quality management, and making sure risks to participant safety, patient safety and data integrity are escalated in time* Assuring the quality systems behind clinical development and pharmacovigilance, including their integration with the enterprise QMS and accurate representation in the Pharmacovigilance System Master File* Overseeing the clinical safety interfaces: SAE collection and reconciliation, SUSAR and expedited reporting, investigator safety reporting, safety data exchange agreements and signal escalation* Running a globally consistent framework for significant quality issues, serious breaches, critical deviations and CAPAs, backed by rigorous root-cause analysis and reportability assessment* Leading GCP and GVP inspection readiness and health-authority inspections, owning the patient-facing audit plan, and giving senior leadership an integrated view of quality risk, trends and regulatory intelligence **Experience Required*** At least 10 years of progressively responsible experience in pharma, biotech or regulated life sciences, with a degree in life sciences, pharmacy, medicine, nursing or a related discipline (an advanced degree or professional certification in Quality, GCP, GVP or auditing is an advantage)* Significant QA leadership in clinical quality, PV quality or both, including leading global teams in a complex matrix; experience across both GCP and GVP is strongly preferred* Expert knowledge of GCP and GVP regulation and inspection expectations, including ICH E6(R3) and the EU GVP framework* A track record with health-authority inspections, serious breaches, investigations, CAPAs and inspection remediation* Hands-on experience of Quality by Design, risk-based quality management, quality metrics, data integrity and computerised systems, as well as oversight of CROs, vendors, affiliates and partners* Experience managing budgets, consultants, workforce plans and talent, and building a team of trusted strategic advisers **Note on travel**This is a global role. Expect some out-of-hours meetings across time zones and periodic international travel.